Jiangxi Fushine Pharmaceutical Co., Ltd. (SHE:300497)
China
· Delayed Price · Currency is CNY 15.71
+0.01 (0.06%)
Mar 10, 2026, 11:54 AM CST
SHE:300497 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 8,457 | 4,492 | 5,042 | 7,110 | 8,887 | 6,586 | Upgrade
|
| Market Cap Growth | 76.40% | -10.90% | -29.09% | -19.99% | 34.93% | 31.47% | Upgrade
|
| Enterprise Value | 9,563 | 5,432 | 5,887 | 7,337 | 8,195 | 6,346 | Upgrade
|
| Last Close Price | 15.70 | 8.34 | 9.36 | 13.20 | 16.33 | 14.04 | Upgrade
|
| PE Ratio | - | - | - | - | 181.99 | 20.63 | Upgrade
|
| Forward PE | - | 29.64 | 29.64 | 29.64 | 19.92 | 14.97 | Upgrade
|
| PS Ratio | 8.72 | 3.81 | 3.13 | 4.32 | 6.22 | 4.41 | Upgrade
|
| PB Ratio | 3.90 | 2.06 | 2.04 | 2.64 | 3.05 | 2.16 | Upgrade
|
| P/TBV Ratio | 4.55 | 2.31 | 2.25 | 2.93 | 3.39 | 2.39 | Upgrade
|
| P/FCF Ratio | - | 97.89 | - | - | - | - | Upgrade
|
| P/OCF Ratio | 127.81 | 23.94 | - | - | 122.88 | 17.23 | Upgrade
|
| EV/Sales Ratio | 9.86 | 4.61 | 3.66 | 4.45 | 5.73 | 4.25 | Upgrade
|
| EV/EBITDA Ratio | - | - | - | 113.16 | 30.17 | 13.85 | Upgrade
|
| EV/EBIT Ratio | - | - | - | - | 47.35 | 16.51 | Upgrade
|
| EV/FCF Ratio | -65.49 | 118.36 | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.79 | 0.74 | 0.66 | 0.53 | 0.34 | 0.14 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | 21.87 | 3.69 | 0.97 | Upgrade
|
| Debt / FCF Ratio | - | 34.97 | - | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.50 | 0.42 | 0.36 | 0.14 | -0.14 | -0.41 | Upgrade
|
| Net Debt / EBITDA Ratio | -463.02 | -48.55 | -83.97 | 6.02 | -1.55 | -2.73 | Upgrade
|
| Net Debt / FCF Ratio | -7.44 | 19.77 | -2.92 | -0.67 | 0.69 | 18.68 | Upgrade
|
| Asset Turnover | 0.21 | 0.25 | 0.33 | 0.34 | 0.33 | 0.45 | Upgrade
|
| Inventory Turnover | 2.21 | 2.63 | 2.98 | 2.96 | 2.83 | 3.41 | Upgrade
|
| Quick Ratio | 0.83 | 0.81 | 1.11 | 1.32 | 1.38 | 2.33 | Upgrade
|
| Current Ratio | 1.15 | 1.09 | 1.46 | 1.77 | 1.70 | 2.67 | Upgrade
|
| Return on Equity (ROE) | -12.25% | -12.07% | -8.65% | -5.86% | 1.33% | 14.08% | Upgrade
|
| Return on Assets (ROA) | -2.50% | -2.53% | -2.15% | -0.76% | 2.48% | 7.23% | Upgrade
|
| Return on Invested Capital (ROIC) | -5.56% | -5.87% | -5.28% | -2.12% | 5.80% | 20.38% | Upgrade
|
| Return on Capital Employed (ROCE) | -5.80% | -6.30% | -4.80% | -1.60% | 5.20% | 12.20% | Upgrade
|
| Earnings Yield | -3.23% | -6.06% | -3.98% | -1.99% | 0.55% | 4.85% | Upgrade
|
| FCF Yield | -1.73% | 1.02% | -6.09% | -8.16% | -6.83% | -1.02% | Upgrade
|
| Dividend Yield | - | - | - | - | - | 1.42% | Upgrade
|
| Payout Ratio | - | - | - | - | 285.02% | 25.65% | Upgrade
|
| Buyback Yield / Dilution | -2.92% | 1.69% | 0.26% | -0.29% | -17.25% | -1.38% | Upgrade
|
| Total Shareholder Return | -2.92% | 1.69% | 0.26% | -0.29% | -17.25% | 0.05% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.